Lancashire and South Cumbria
Formulary
Formulary
12 Ear, nose and oropharynx
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
12-03-05 Systemic treatment
| Pilocarpine Salagen® |
|
Formulary
|
Tablets 5mg Radiation-induced xerostomia, Sjogren’s syndrome When 1st line topical agents have not been effective |
|
| Pilocarpine Hydrochloride |
|
Formulary
|
Approved for Sjogrens Syndrome for severe cases that are unresponsive to pastilles and/or artificial saliva spray - Specialist initiation |
|
|
Links
LSCMMG: Gastroenterology Biologics Pathway- LSCMMG: Primary Care Constipation Guidelines
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people